Vertex Pharmaceuticals Science Profile Banner
Vertex Pharmaceuticals Science Profile
Vertex Pharmaceuticals Science

@VertexScience

8,338
Followers
8
Following
458
Media
637
Statuses

Official channel for news and info about @VertexPharma  science and emerging technologies. Intended for U.S. HCPs and scientific community.

Boston, MA
Joined September 2020
Don't wanna be here? Send us removal request.
@VertexScience
Vertex Pharmaceuticals Science
1 year
Check out this video on @NKF featuring NBA star Alonzo Mourning and his nephrologist, Dr. Gerald Appel, who discussed Alonzo’s journey with APOL1-mediated #KidneyDisease . Alonzo Mourning is a paid spokesperson for Vertex Pharmaceuticals. Watch here:
29
240
2K
@VertexScience
Vertex Pharmaceuticals Science
10 months
It's important for physicians to be aware of APOL1-mediated kidney disease (AMKD) and how to be proactive about detecting it. Vertex’s Dr. Ogo Egbuna and 🏀 Hall-of-Famer @iamzo33 are presenting at #NMANOLA23 to raise awareness. Learn more about AMKD at .
Tweet media one
19
200
2K
@VertexScience
Vertex Pharmaceuticals Science
1 year
The #CysticFibrosis (CF) community is what drives us to do all that we can to research & develop the next generation of therapies for people living with CF. This month, & always, we remain steadfast in our pursuit. #CFAwarenessMonth #GoingtheDistanceinCF
Tweet media one
18
149
2K
@VertexScience
Vertex Pharmaceuticals Science
9 months
During #PainAwarenessMonth , we are honored to sponsor the @PAINWeek 2023 #PAINWeek National Conference alongside others in the #pain community as we work toward a potential treatment. Learn more:
30
163
1K
@VertexScience
Vertex Pharmaceuticals Science
9 months
Our dedication to the cystic fibrosis (CF) community extends beyond our research & development efforts. Vertex funds innovative patient-centric programs that support people with CF to live fuller, more engaged lifestyles through our Circle of Care grant:
20
173
1K
@VertexScience
Vertex Pharmaceuticals Science
1 year
Our teams had a great time at @theEBMT ’s Annual Meeting to hear and share insights in the #Hematology space while our scientists work to advance our research in #SickleCellDisease and #BetaThalassemia . Learn more: #EMBT2023
Tweet media one
19
116
1K
@VertexScience
Vertex Pharmaceuticals Science
10 months
Our scientists don’t see the impossible as an obstacle, they see it as a good place to start. Listen to Fred Van Goor, VP, CF Research, talk about our commitment to pursuing new therapeutic advances for people living with #CysticFibrosis #GoingtheDistanceinCF
14
157
1K
@VertexScience
Vertex Pharmaceuticals Science
6 months
We were honored to support @CF_Foundation ’s #NACFC2023 last week alongside our peers in the #CysticFibrosis space.
41
154
1K
@VertexScience
Vertex Pharmaceuticals Science
9 months
Gene editing is being researched to treat many genetic disorders. One method allows for cells to be carefully edited outside of the body, or ex vivo. Watch the animation to learn more about this innovative technique.
19
138
1K
@VertexScience
Vertex Pharmaceuticals Science
9 months
Vertex’s Health Economics and Outcomes Research team is looking forward to sharing their poster presentation on the societal burden of opioid use at #PAINWeek 2023.
22
109
1K
@VertexScience
Vertex Pharmaceuticals Science
10 months
Our journey in discovering treatments for certain rare diseases began more than two decades ago with #CysticFibrosis . Since then, we’ve remained true to science & continue to work tirelessly toward reaching all people with CF. Learn more about our history and path forward in CF.
24
140
1K
@VertexScience
Vertex Pharmaceuticals Science
3 years
Visit to read a debrief of #ASGCT21 by our Chief of Cell and Genetic Therapies, Bastiano Sanna. We were excited to sponsor and present our work in the area at @ASGCTherapy 's virtual meeting.
10
48
1K
@VertexScience
Vertex Pharmaceuticals Science
10 months
Listen to Rebecca Hunt, Vice President of Patient & Community Engagement talk about our commitment to #GoingtheDistanceinCF for the community that has been there at every step of our 20+ year journey :
6
151
1K
@VertexScience
Vertex Pharmaceuticals Science
10 months
Our work in type 1 diabetes (T1D) began with two parents learning to manage a lifelong disease that their son was born with. Hear the story of Doug Melton, whose family inspired him to turn his research towards approaches for potential treatments for T1D.
13
168
1K
@VertexScience
Vertex Pharmaceuticals Science
1 year
🏀 hall-of-famer Alonzo Mourning was featured on @nbc6 to talk about his journey with APOL1-mediated kidney disease. Watch this video to hear him talk about his experience. Alonzo Mourning is a paid spokesperson for Vertex Pharmaceuticals.
8
147
1K
@VertexScience
Vertex Pharmaceuticals Science
9 months
Today we come together to raise awareness for #DuchenneMuscularDystrophy . Watch our video to understand the impact of this condition and why we recognize #WorldDuchenneAwarenessDay .
26
109
1K
@VertexScience
Vertex Pharmaceuticals Science
8 months
Each September, we’re proud to recognize #DuchenneActionMonth as we research a potential treatment for #DuchenneMuscularDystrophy (DMD).
20
95
982
@VertexScience
Vertex Pharmaceuticals Science
11 months
It was a privilege to attend @FundSickleCell ’s 17th Annual Sickle Cell Disease Research & Education Symposium to hear about scientific advances in #SCD . Learn more:
Tweet media one
3
41
847
@VertexScience
Vertex Pharmaceuticals Science
7 months
Patients are the “why” behind our work at Vertex. This November, we’re proud to support the many patients, families and caregivers affected by alpha-1 antitrypsin deficiency (AATD) to help raise awareness and amplify the voices of alpha-1 community. #Alpha1AwarenessMonth
26
114
699
@VertexScience
Vertex Pharmaceuticals Science
7 months
Our work in type 1 diabetes (T1D) was inspired by two parents learning to manage a lifelong disease their son was born with. Hear from Dr. Doug Melton, whose family motivated him to turn his research toward potential new treatments for T1D. #DiabetesAwarenessMonth
31
126
676
@VertexScience
Vertex Pharmaceuticals Science
3 years
Our scientists don’t see the impossible as an obstacle, they see it as a good place to start. Check out @statnews to see our illustrated approach to researching potential treatments for #sicklecelldisease #betathalassemia and #type1diabetes .
6
60
631
@VertexScience
Vertex Pharmaceuticals Science
1 year
It’s #NationalKidneyMonth , and we’re proud to amplify the stories of those affected by APOL1-mediated #KidneyDisease (AMKD). Check out this animated video to hear from Dr. Kendra Richardson (who is living with AMKD) and learn about her journey to a diagnosis.
3
66
651
@VertexScience
Vertex Pharmaceuticals Science
1 year
Our journey in discovering treatments for certain rare diseases began more than two decades ago with #CysticFibrosis . Since then, we’ve remained true to science & continue to work tirelessly toward reaching all people with CF. Learn more about our history & path forward in CF.
9
47
629
@VertexScience
Vertex Pharmaceuticals Science
1 year
March 9th is @WorldKidneyDay . We’re proud to support @ISNkidneycare in raising awareness for #KidneyHealthForAll . Learn more:
Tweet media one
7
67
628
@VertexScience
Vertex Pharmaceuticals Science
9 months
Our global team is working tirelessly with the goal of helping people living with #Pain . It’s our privilege to join the community in recognizing September as #PainAwarenessMonth .
12
60
636
@VertexScience
Vertex Pharmaceuticals Science
1 year
Listen to Rebecca Hunt, Vice President of Patient & Community Engagement talk about our commitment to #GoingtheDistanceinCF for the community that has been there at every step of our 20+ year journey:
7
48
526
@VertexScience
Vertex Pharmaceuticals Science
11 months
Want to learn how a genetic therapy is manufactured? Come behind the scenes with us to learn about the innovative cell and genetic therapy manufacturing process and see each of the steps involved.
12
38
544
@VertexScience
Vertex Pharmaceuticals Science
6 months
November 14 is World Diabetes Day, a chance to shed light on the burdens impacting millions of people living with diabetes across the globe. Learn more in this animation:
25
83
503
@VertexScience
Vertex Pharmaceuticals Science
11 months
We’re grateful to be sponsoring #ISSCR2023 here in Boston to learn about advances in #stemcell research. Learn more about our programs here:
Tweet media one
3
44
483
@VertexScience
Vertex Pharmaceuticals Science
8 months
We are proud to sponsor the 2023 @CanHaem Annual Conference and AGM this week alongside dedicated clinicians. Hearing about advances in sickle cell disease and beta thalassemia is invigorating for our teams at Vertex!
Tweet media one
7
57
417
@VertexScience
Vertex Pharmaceuticals Science
6 months
November is #Alpha1AwarenessMonth , and we’re proud to join the community as we recognize the patients, caregivers and families affected by alpha-1 antitrypsin deficiency (AATD). You can learn more about #AATD and our research toward a potential treatment below:
20
68
430
@VertexScience
Vertex Pharmaceuticals Science
1 year
At Vertex, our goal is to improve the lives of people living with serious diseases. In honor of #InternationalThalassemiaDay , watch this animation to learn more about the disease and our role. #betathalassemia
2
26
395
@VertexScience
Vertex Pharmaceuticals Science
3 years
As strong believers in the next generation of cystic fibrosis (CF) researchers, it is our goal to help support and inspire innovation through our Research Innovation Awards. Learn more about our CF grants programs and how to apply: #GoingtheDistanceinCF
7
17
320
@VertexScience
Vertex Pharmaceuticals Science
11 months
It was great to be a sponsor of @CooleysAnemia ’s Patient-Family conference in Los Angeles last week to connect with and learn from people impacted by #BetaThalassemia . Learn more:
Tweet media one
2
31
326
@VertexScience
Vertex Pharmaceuticals Science
3 years
Our commitment to the community extends beyond drug development. Circle of Care is an annual grant opportunity that funds innovative, patient-centric programs for people with CF. Learn more and how to apply today: #GoingtheDistanceinCF
0
13
221
@VertexScience
Vertex Pharmaceuticals Science
1 year
The patient voice is integral to us at Vertex. That’s why we’re excited to attend @diaTribenews ’s free panel discussion, “Managing Hypoglycemia & Hypo Unawareness: Is Technology Enough?” to listen & learn alongside the #type1diabetes community. Learn more:
Tweet media one
0
12
215
@VertexScience
Vertex Pharmaceuticals Science
9 months
It’s #PainAwarenessMonth , and we’re proud to support the U.S. Pain Foundation and its work to educate, empower, connect and advocate for people living with #pain . Stay tuned to @US_Pain channels this month to learn more:
Tweet media one
27
49
234
@VertexScience
Vertex Pharmaceuticals Science
3 years
At Vertex, we‘re investigating potential treatments for sickle cell disease. It’s a privilege to participate in the 10th Annual Sickle Cell Disease Therapeutics Conference this #sicklecellawarenessmonth alongside our peers. Learn more at:
5
42
189
@VertexScience
Vertex Pharmaceuticals Science
9 months
Alongside our work researching potential treatments for APOL1-mediated  #KidneyDisease  (AMKD), we’re proud to support  @KidneyFund  & the kidney community to drive innovation in research, diagnosis & treatment of the underlying causes of kidney disease:
2
8
186
@VertexScience
Vertex Pharmaceuticals Science
7 months
Pain – both common and complex –affects people differently and is influenced by things like genetics, gender, and age. We’re thinking differently about the condition by trying to target pain where it starts. Learn how on Targeting the Toughest Diseases:
7
4
160
@VertexScience
Vertex Pharmaceuticals Science
6 months
We look forward to connecting with attendees at @SCCConsortium ’s 3rd Annual Sickle Cell Caregiver Summit and learning from the wonderful caregivers in the #SickleCellDisease community. Learn more:
Tweet media one
6
5
150
@VertexScience
Vertex Pharmaceuticals Science
1 year
Want to join a team dedicated to improving the lives of people using innovative technology such as gene and cell therapy? Come meet us at @ASGCTherapy ’s 26th Annual Meeting at booth 841. #ASGCT2023
Tweet media one
0
14
140
@VertexScience
Vertex Pharmaceuticals Science
2 years
Congrats to our Sr. VP of Research, Paul Negulescu, for receiving the 2022 Shaw Prize in Life Sciences in Medicine for his work in #CF ! This award recognizes unique individuals who have recently made distinguished and significant advances in their field.
Tweet media one
6
19
151
@VertexScience
Vertex Pharmaceuticals Science
3 years
As we continue to work on potential treatments for #type1diabetes , it’s exciting to see this @Nature timeline of over 100 years of research, including contributions from Doug Melton, and Vertex’s Felicia Pagliuca and David Altshuler. Learn more:
7
24
142
@VertexScience
Vertex Pharmaceuticals Science
7 months
We’re excited to sponsor this year’s @SCDAAorg Annual Convention in company with experts in #sicklecelldisease research, advocates, and warriors. Stop by our booth!
Tweet media one
4
13
143
@VertexScience
Vertex Pharmaceuticals Science
7 months
Risk variants in the APOL1 gene the cause of APOL1-mediated kidney disease – only affect people of African ancestry. Hear how scientists are using this understanding of the disease & applying it to cutting-edge research on Targeting the Toughest Diseases:
Tweet media one
6
4
139
@VertexScience
Vertex Pharmaceuticals Science
11 months
Patients are at the center of everything we do at Vertex. It’s our privilege to be sponsoring @CooleysAnemia ’s Patient-Family Conference in Los Angeles to connect with the #BetaThalassemia community. Learn more:
Tweet media one
3
16
133
@VertexScience
Vertex Pharmaceuticals Science
7 months
Type 1 diabetes (T1D) needs constant vigilance, burdening caregivers & those living with this condition. For #DiabetesAwarenessMonth , hear from Vertex researchers Drs. Doug Melton & Felicia Pagliuca on why we are investigating the underlying cause of #T1D :
6
8
129
@VertexScience
Vertex Pharmaceuticals Science
6 months
A new study from our Health Economics and Outcomes Research team has for the first time quantified health care prejudice experienced by people living with #SickleCellDisease . Learn more:
Tweet media one
4
6
129
@VertexScience
Vertex Pharmaceuticals Science
8 months
We are proud to be a sponsor of this week’s @BHMinfo Fall 2023 Health Summit together with our peers and the community. Come visit us at our booth!
Tweet media one
19
19
112
@VertexScience
Vertex Pharmaceuticals Science
7 months
Alongside our work researching potential treatments for APOL1-mediated  #KidneyDisease  (AMKD), we’re proud to support  @KidneyFund  & the kidney community to drive innovation in research, diagnosis & treatment of the underlying causes of kidney disease:
2
6
113
@VertexScience
Vertex Pharmaceuticals Science
9 months
Pain – both common and complex –affects people differently and is influenced by things like genetics, gender, and age. We’re thinking differently about the condition by trying to target pain where it starts. Learn how on Targeting the Toughest Diseases:
6
4
99
@VertexScience
Vertex Pharmaceuticals Science
2 years
As we recognize CF Awareness Month, we celebrate the progress made to advance the care for people with CF but also acknowledge the work that lies ahead in our path forward. Learn more: #CFAwarenessMonth #GoingtheDistanceinCF
Tweet media one
1
27
112
@VertexScience
Vertex Pharmaceuticals Science
8 months
It was a privilege to attend the @EASDnews Annual Meeting last week. Our #T1D team was thrilled to participate alongside experts in the field as we continue our work pursuing a potential treatment for those living with #type1diabetes . Learn more at
Tweet media one
10
7
104
@VertexScience
Vertex Pharmaceuticals Science
8 months
We know that people with #Type1Diabetes are missing insulin-producing cells. Our research teams are applying our deep understanding of this causal human biology to our research, at the cellular level. Learn more:
17
11
96
@VertexScience
Vertex Pharmaceuticals Science
6 months
Are you an early career physician scientist looking to make an impact? Applications are open for the next cohort of our Vertex Physician Investigators! Learn about this two-year rotational program, meet recent participants and apply now: .
7
2
90
@VertexScience
Vertex Pharmaceuticals Science
9 months
Living with #Type1Diabetes can be a 24/7 job for people with the disease. Despite advances in managing it, there’s still no cure. This unmet need drives our investigation into #T1D – at a cellular level. Hear more on Targeting the Toughest Diseases:
4
9
86
@VertexScience
Vertex Pharmaceuticals Science
8 months
We’re committed to inspiring the next generation of #CysticFibrosis research-focused PhDs and MDs through our competitive cystic fibrosis (CF) award programs. Is this you or someone you know? Apply today:
Tweet media one
8
9
85
@VertexScience
Vertex Pharmaceuticals Science
6 months
It was great to be at @ASNKidney ’s #KidneyWeek to hear about research in #KidneyDisease and join the conversation in this space. Learn more about our research in APOL1-mediated kidney disease (AMKD) in this animated video:
2
6
94
@VertexScience
Vertex Pharmaceuticals Science
3 years
It’s #PainAwarenessMonth , and we’re proud to join the community in recognition of the many patients, caregivers and families whose lives are affected by this debilitating disorder. Watch this video to learn more about science of #pain & our research toward a potential treatment:
2
17
76
@VertexScience
Vertex Pharmaceuticals Science
7 months
Our Health Economics and Outcomes Research team was honored to present their latest #HealthEquity research findings in #SickleCellDisease at the 30th @ISOQOL Annual Conference last week.
Tweet media one
0
10
75
@VertexScience
Vertex Pharmaceuticals Science
3 years
Every day, we’re inspired by the patient communities we serve. We’re proud to light up our #Boston building red, blue and green to kick off #WorldSickleCellDay , #PainAwarenessMonth , and #DuchenneActionMonth to raise awareness for the fight against these diseases.
Tweet media one
9
5
69
@VertexScience
Vertex Pharmaceuticals Science
8 months
For LiNa Loo, each data point represents another step or steering point forward in research for #DuchenneMuscularDystrophy . To learn more about what working in #DMD means to LiNa and 4 other female scientists, read more:
Tweet media one
4
3
72
@VertexScience
Vertex Pharmaceuticals Science
3 years
For Bastiano Sanna, Chief of Vertex Cell and Genetic Therapies, our commitment to serious diseases like beta thalassemia hits close to home. Read about his story and another Vertexian’s personal experience that sparked our work in #hemoglobinopathies .
4
13
74
@VertexScience
Vertex Pharmaceuticals Science
3 years
CRISPR/Cas9 gene editing is an exciting tool that is used in our investigational program for #sicklecelldisease and #betathalassemia , two genetic blood disorders. Watch the animation below to learn how this technology works. #CRISPR
23
20
76
@VertexScience
Vertex Pharmaceuticals Science
3 years
We’re excited to kickoff #SickleCellAwarenessMonth and to sponsor this year’s @husicklecell ’s Cure Sickle Cell Now Move-On events. Learn more about these activities and how to join us in recognizing #SickleCellAwarenessMonth here:
0
32
81
@VertexScience
Vertex Pharmaceuticals Science
3 years
At Vertex, our team is working tirelessly in the hopes of developing potential treatments for type 1 diabetes. It’s great to be at the @ESOTtransplant biennial congress this week alongside experts in the #transplantation field. Learn more at:
0
9
67
@VertexScience
Vertex Pharmaceuticals Science
1 year
We’re excited to be at #ACCE2023 alongside clinicians in endocrinology as we continue our work pursuing a potential treatment for those living with #T1D . Learn more about our programs here:
0
0
30
@VertexScience
Vertex Pharmaceuticals Science
2 years
Vice President of Clinical Development for Vertex Cell and Genetic Therapies, Bill Hobbs, had the honor to discuss Vertex’s innovative approach in gene editing for sickle cell disease at @StJudeResearch ’s event, “Sickle Cell Disease: What’s New with Transplant and Gene Therapy?”
Tweet media one
2
15
75
@VertexScience
Vertex Pharmaceuticals Science
3 years
It was an honor to be at the #ADA2021 Scientific Sessions this week where we shared the story of our work in #type1diabetes . Check out the video below to hear from some of our leaders in this program.
2
3
65
@VertexScience
Vertex Pharmaceuticals Science
2 years
We are truly inspired by the #cysticfibrosis community. It is what keeps us moving as we progress forward in our research for all people living with CF. #CFAwarenessMonth #GoingtheDistance
1
11
69
@VertexScience
Vertex Pharmaceuticals Science
6 months
It was a privilege to attend the @AmDiabetesAssn State of Diabetes event and hear from experts in the field and the #Type1Diabetes community. #DiabetesAwarenessMonth Learn more:
Tweet media one
7
8
66
@VertexScience
Vertex Pharmaceuticals Science
6 months
Catch our Health Economics and Outcomes Research team at #ISPOREurope this week! They’ll present data on how #SickleCellDisease and #BetaThalassemia can affect productivity and how potential interventions may impact quality of life. Learn more:
Tweet media one
6
2
60
@VertexScience
Vertex Pharmaceuticals Science
2 years
Today is #WorldSickleCellDay and we’re recognizing the fearlessness of #SickleCellWarriors and their caregivers. Meet Mapillar Dahn, the mother of and caregiver for three daughters living with #SickleCellDisease . Hear more about her story and the many impacts of #SCD .
4
19
65
@VertexScience
Vertex Pharmaceuticals Science
2 years
#WorldSickleCellDay is Sunday, and our Boston office is lighting up red to support #sicklecellwarriors and honor the fearlessness of #sicklecelldisease patients, caregivers and advocates. Visit to join us in raising awareness for #SCD .
Tweet media one
0
24
59
@VertexScience
Vertex Pharmaceuticals Science
3 years
Motivated by the research you heard about at #EHA2021 ? Come work at Vertex! Our teams are hard at work researching potential genetic therapies for sickle cell disease and beta thalassemia.
Tweet media one
4
8
51
@VertexScience
Vertex Pharmaceuticals Science
3 years
We’re excited to join the annual @ESPNSociety Scientific Meeting to learn from experts in the field as we continue our work pursuing a potential treatment for those living with APOL1-mediated kidney disease. Learn more: .
1
12
56
@VertexScience
Vertex Pharmaceuticals Science
3 years
It’s our privilege to participate in today’s Coverage for Sickle Cell Disease Summit hosted by @SickCells to connect with the medical and patient #sicklecell community to hear their stories and learn how we can help make a difference. Learn more at:
4
12
59
@VertexScience
Vertex Pharmaceuticals Science
9 months
Sometimes a known problem needs a bespoke solution. This mindset is what inspires our investigational approach using gene-editing technology. Listen to the latest episode of Targeting the Toughest Diseases:
1
1
52
@VertexScience
Vertex Pharmaceuticals Science
3 years
For people like Jon living with #betathalassemia , his weeks are controlled by the schedule of frequent blood transfusions that provide healthy donated blood. Learn about the burden of managing beta thalassemia:
2
8
56
@VertexScience
Vertex Pharmaceuticals Science
3 years
This year marks the 100th anniversary of insulin’s discovery in 1921. This holds special meaning to us as we continue our work on a potential cell therapy to treat people living with #type1diabetes . Looking forward to the possibility of what’s yet to come. #Insulin100
Tweet media one
6
6
46
@VertexScience
Vertex Pharmaceuticals Science
8 months
We’re working tirelessly to develop potential treatments for APOL1-mediated kidney disease ( #AMKD ). It was great to be at @Nephcure ’s Allied Leadership Conference to hear from leaders in the #KidneyDisease space. Learn more:
Tweet media one
8
6
59
@VertexScience
Vertex Pharmaceuticals Science
2 years
Our teams from across the globe came together at this year’s EHA2022 Congress in Vienna, Austria. It was an invigorating experience to join our peers as we continue our work in #SickleCellDisease and #BetaThalassemia .
Tweet media one
1
1
53
@VertexScience
Vertex Pharmaceuticals Science
2 years
“The illness that my sisters and I have, #SickleCellDisease , is the leading cause of stroke in children.” Hear from 17-year-old Amatullah (Tully) as she recounts watching her sister experience a stroke at the age of 7 and how that shaped her own career aspirations.
18
6
46
@VertexScience
Vertex Pharmaceuticals Science
3 years
Learn how we’re breaking through roadblocks and solving complex problems from our Senior Director of Instrumentation R&D, James Sinclair, in this animated video:
0
5
49
@VertexScience
Vertex Pharmaceuticals Science
3 years
It’s #SickleCellAwarenessMonth and #DuchenneActionMonth ! At Vertex, we're dedicated to exploring new possibilities in treating these diseases. Check out the video below to learn how CRISPR/Cas9 gene editing works.
0
12
47
@VertexScience
Vertex Pharmaceuticals Science
2 years
We look forward to connecting with attendees at @GlobalSCDN ’s 4th Global Congress on Sickle Cell Disease in Paris to hear about scientific research in the #SCD space. #GCSCD2022
Tweet media one
2
13
48
@VertexScience
Vertex Pharmaceuticals Science
7 months
It’s great to be participating in Anesthesiology 2023 hosted by @ASALifeline to hear about #pain research and join the conversation. Come visit us at our booth!
Tweet media one
3
5
50
@VertexScience
Vertex Pharmaceuticals Science
3 years
It’s a privilege for us to take part in the 2nd Annual Gene Therapy for Blood Disorders Conference this week (March 9-11). We’re looking forward to learning from our peers as we continue our work on potential treatments for #sicklecelldisease and #betathalassemia
3
4
40
@VertexScience
Vertex Pharmaceuticals Science
1 year
We’re proud to sponsor a special @NKF Facebook Live event ft. 🏀 hall-of-famer Alonzo Mourning & his nephrologist, Dr. Gerald Appel, where they’ll talk about Zo’s journey with APOL1-mediated #KidneyDisease & more. Tune in on March 31: #NationalKidneyMonth
1
6
41
@VertexScience
Vertex Pharmaceuticals Science
3 years
At Vertex, we’re investigating the use of different tools, technologies and modalities—including small molecules—to potentially treat those living with #pain and other serious diseases. Check out this animation to learn more about small molecules and how they work.
2
5
40
@VertexScience
Vertex Pharmaceuticals Science
6 months
We’re excited to participate at the @JDRF Type One Nation Summit next week, alongside caregivers, families, and individuals in the #Type1Diabetes community. Learn more:
Tweet media one
0
0
36
@VertexScience
Vertex Pharmaceuticals Science
3 years
This September, we’re recognizing #SickleCellAwarenessMonth to shine a light on the dedicated community of patients and caregivers, and the efforts around the world to help improve the lives of those with #sicklecelldisease . Watch the video for more.
0
16
39
@VertexScience
Vertex Pharmaceuticals Science
2 years
It was so intense that I couldn’t even control myself—I couldn’t walk, I was just crying.” Watch this video of #Sicklecellwarrior Tosin Ola as she shares the impact of #sicklecelldisease on her every day. #ASH21
3
7
38
@VertexScience
Vertex Pharmaceuticals Science
3 years
Welcome to the Vertex Science Twitter channel! Join us here to learn about our #research and #science , get updates on our pipeline, our participation in conferences around the globe and spotlights on our world-class scientists and the incredible patients we serve.
Tweet media one
3
12
33